 | Articles: Drug Trials |

Switching to quetiapine in patients with acute mania who were intolerant to risperidone
Human Psychopharmacology: Clinical and Experimental, 01/16/04
Differential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trial
Cardiovascular Diabetology, 01/16/04
Statins in hypercholesterolaemia: A dose-specific meta-analysis of lipid changes in randomised, double blind trials
BMC Clinical Pharmacology, 01/16/04
|
| | Sponsor |
Selecting outcome parameters in studies aimed at improving rational use of antibiotics ¿ practical considerations
Journal of Clinical Pharmacy and Therapeutics, 01/16/04
Aminoglycoside and vancomycin serum concentration monitoring and mortality due to neonatal sepsis in Saudi Arabia
Journal of Clinical Pharmacy and Therapeutics, 01/16/04
Tolmetin and salicylate therapy in acute rheumatic fever: Comparison of clinical efficacy and side-effects
Pediatrics International, 01/16/04
Does lithium save lives?
Journal of Psychiatry & Neuroscience , 01/15/04
Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: Results of a randomized, double-blind, placebo-controlled multicenter study
Critical Care Medicine, 01/15/04
Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: Results of a randomized, double-blind, placebo-controlled multicenter study
Critical Care Medicine, 01/15/04
Linezolid for treatment of ventilator-associated pneumonia: A cost-effective alternative to vancomycin
Critical Care Medicine, 01/15/04
|
Receive daily email updates on Drug Trials
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
 |
 |
| Read a Different Specialty |
 |
|
|
|
 |
| Profession Index |
 |
|
|
|
 |
|
|
|
| Sponsor |
|